AI in drug discovery – what it is, where we stand and the path forward

Related Stories

• How Congressional lawmakers and aides are using AI tools with little oversight to write speeches and news releases, sort constituent mail, and more
• Have a laugh at AI’s expense by roleplaying as a chatbot
• Sources: Nvidia in talks to invest up to $3B in SoftBank-backed data center developer SB Energy that aims to IPO soon and is behind a huge OpenAI campus in Ohio
• An eval harness found what qualitative review couldn't: AI models are most confident when wrong
• Anthropic shares more details about how Claude’s new watermarks will work